Risultati per: FDA approva un nuovo trattamento per l’emicrania

Al parco Bam di Milano evento dedicato alla patologia

The US Food and Drug Administration (FDA) green-lit the first vaccine against respiratory syncytial virus (RSV). The vaccine, marketed as Arexvy, is approved for people aged 60 years or older, the FDA said in a statement.

Dai saponi ai prodotti per pulire, dai fiori a quelli disgustosi

Il tema «Fine Vita: una questione ancora aperta», è il titolo del primo appuntamento della Road map di Aisla che si è tenuto a Palermo

Evento al Bam di Milano, tra talk e laboratori di mindfulness

Aumento storico del 20% grazie ai contributi fissi degli Stati

People who are aged 65 years or older and have gotten 1 dose of a bivalent COVID-19 vaccine can now receive another at least 4 months after their previous dose, according to a statement by the US Food and Drug Administration (FDA). People who are immunocompromised and have received a bivalent COVID-19 vaccine can also get another after a minimum of 2 months.

Lundbeck Italia, aiutiamo i malati a uscire dall’invisibilità

Lundbeck Italia, aiutiamo i malati a uscire dall’invisibilità

Lundbeck Italia, aiutiamo i malati a uscire dall’invisibilità

Prepared by isolating firmicutes spores from screened donors, VOWST is currently the only FDA-approved oral FMT option.

Vilobelimab, marketed as Gohibic, has received Emergency Use Authorization from the US Food and Drug Administration (FDA) for patients with severe COVID-19 symptoms. The drug, an anti-C5a monoclonal antibody that targets an inflammatory pathway believed to be involved in COVID-19 progression, is authorized for use in hospitalized patients with COVID-19 within 48 hours of starting invasive mechanical ventilation or extracorporeal membrane oxygenation, according to the FDA announcement.